Circulating circular RNAs as biomarkers for the diagnosis of essential hypertension with carotid plaque

• Published in: Clinical and experimental hypertension (1993) Vol. 44; no. 7; pp. 601 - 609
• Main Authors: Zhang, Zebo, Qian, Haiyan, Tao, Zhenbo, Xie, Yanqing, Zhi, Shuai, Sheng, Liufang, He, Wenming, Zhang, Lina
• Format: Journal Article
• Language: English
• Published: Taylor & Francis 03.10.2022; Taylor & Francis Group
• Subjects: biomarker; carotid plaque; circular RNA; Essential hypertension; subclinical target organ injury
• ISSN: 1064-1963; 1525-6006
• DOI: 10.1080/10641963.2022.2093894

At present, no early diagnostic markers for essential hypertension (EH)-induced subclinical target organs damage (such as carotid plaque) are available. This study aimed to identify the circular RNAs (circRNAs) in EH with carotid plaques, and assess their utility as biomarkers. First, circRNAs were identified through microarry analysis and database prediction. Second, a case-control study of EH patients with carotid plaque (n = 100) and healthy controls (n = 100) was performed to evaluate circRNAs expression in peripheral blood. Finally, receiver operating characteristic (ROC) curve was established to evaluate the diagnostic value. Five circRNAs (hsa_circ_0105130, hsa_circ_0109569, hsa_circ_0072659, hsa_circ_0079586 and hsa_circ_0064684) were identified as the candidate circRNAs. We found that circRNAs were increased in case group compared with controls (P < .05). The results of ROC shown that these five circRNAs, especially hsa_circ_0109569 (AUC = 0.741), all had the moderate predictive value. Our study revealed circulating circRNAs may act as promising noninvasive biomarkers for early detection and population screening of EH-induced subclinical target organ injury.